| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
SUZB3
|
45.30 | 55.9B | 4.45 | 1.16 | 4.03 | 5.0% | 9.3% | 75 | 53 | 91.95 | +74.2% | 58 | 2.03 |
|
RENT3
|
35.07 | 37.3B | 16.55 | 1.42 | 5.33 | 9.4% | 15.1% | 58 | 35 | 47.47 | +23.7% | 49 | 1.64 |
|
RAIL3
|
15.08 | 28.0B | 26.91 | 2.01 | 6.87 | 9.7% | 11.6% | 45 | 36 | 12.12 | -13.1% | 52 | 1.95 |
|
KLBN11
|
18.90 | 116.1B | 100.00 | 12.84 | 16.04 | 5.0% | 15.2% | 29 | 17 | 5.44 | -51.3% | 47 | 3.91 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.